FAQs
What are ROVI's activities in the pharmaceutical market at present?
In which pharmaceutical areas is ROVI present?
What are the main factors in ROVI’s strategy?
News
10/05/2023
First quarter 2023 results press release
ROVI REACHED 201.9 MILLION EUROS OF REVENUE IN THE FIRST POST-PANDEMIC QUARTER
25/04/2023
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
ROVI COMMENCES CLINICAL DEVELOPMENT OF A NEW THREE-MONTHLY FORMULATION OF LETROZOLE (LETROZOLE LEBE)
12/04/2023
Contact
At ROVI, we have a policy of transparency and direct communication. Therefore, you may contact us directly whenever you need to do so.
ROVI
Head Offices
Julián Camarillo 35
28037 Madrid - Spain
28037 Madrid - Spain
Tel +(34) 91 375 62 30
Fax +(34) 91 375 62 30
Email: rovi@rovi.es